Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (1): 228-237.doi: 10.13481/j.1671-587X.20250128
• Imageology • Previous Articles Next Articles
Chaolong JIN1,Xuegong SHI1(
),Chengxin ZHANG2,Youfeng LIANG3,Jie XIAO1,Zhe SHENG1,Dingxin ZHANG1
Received:2024-01-21
Accepted:2024-05-14
Online:2025-01-28
Published:2025-03-06
Contact:
Xuegong SHI
E-mail:shixgay@sohu.com
CLC Number:
Chaolong JIN,Xuegong SHI,Chengxin ZHANG,Youfeng LIANG,Jie XIAO,Zhe SHENG,Dingxin ZHANG. Application of echocardiography in early efficacy evaluation after transapical transcatheter aortic valve replacement via transapical approach[J].Journal of Jilin University(Medicine Edition), 2025, 51(1): 228-237.
Tab.1
General characteristics of patients in various groups before operation"
| Characteristic | AS Group(n=20) | AR Group(n=37) | AS&AR Group(n=28) | F/χ2 | P |
|---|---|---|---|---|---|
| Age(x±s, year) | 71.60±4.58 | 69.70±8.10 | 70.11±11.59 | 1.239 | 0.058 |
| Gender [n(%)] | 2.992 | 0.245 | |||
| Male | 9(45.0) | 25(67.6) | 15(53.6) | ||
| Female | 11(55.0) | 12(32.4) | 13(46.4) | ||
| Height(x±s, cm) | 160.90±8.30 | 161.78±6.68 | 160.54±10.60 | 1.457 | 0.830 |
| Weight(x±s, kg) | 63.18±11.39 | 62.92±9.81 | 63.43±10.76 | 0.019 | 0.981 |
| History of smoking [n(%)] | 2.033 | 0.391 | |||
| Yes | 8(40.0) | 10(27.0) | 6(21.4) | ||
| No | 12(60.0) | 27(73.0) | 22(78.6) | ||
| Classification of cardiac function [n(%)] | - | 0.612* | |||
| Ⅱ | 0(0.0) | 2(5.4) | 0(0.0) | ||
| Ⅲ | 13(65.0) | 27(73.0) | 20(71.4) | ||
| Ⅳ | 7(35.0) | 8(21.6) | 8(28.6) | ||
| Hypertension [n(%)] | 10(50.0) | 15(40.5) | 13(46.4) | 0.520 | 0.819 |
| CHD [n(%)] | 11(55.0) | 15(40.5) | 10(35.7) | 1.865 | 0.409 |
| Diabetes [n(%)] | 1(5.0) | 1(2.7) | 0(0.0) | - | 0.710* |
| Hyperlipidemia [n(%)] | 0(0.0) | 0(0.0) | 1(3.6) | - | 0.565* |
| Renal insufficiency [n(%)] | 5(25.0) | 7(18.9) | 6(21.4) | - | 0.942 |
| Arrhythmology [n(%)] | 10(50.0) | 13(35.1) | 10(35.7) | 1.378 | 0.512 |
Tab.2
Echocardiography parameters of patients in various groups before operation, 1 week after operation, 3 months after operation and 6 months after peration"
| Clinical data | Group | n | Before operation | 1 week after operation | 3 months after operation | 6 months after operation | F | P |
|---|---|---|---|---|---|---|---|---|
LVEDV(mL) | AS | 20 | 139±40 | 130±39 | 118±35 | 100±25* | 4.62 | 0.005 |
| AR | 37 | 233±52 | 207±52 | 181±51* | 150±43* | 18.93 | <0.001 | |
| AS&AR | 28 | 180±46 | 158±41 | 138±35* | 118±30* | 13.21 | <0.001 | |
LVESV(mL) | AS | 20 | 71±33 | 63±30 | 54±25 | 37±11* | 6.23 | 0.001 |
| AR | 37 | 129±42 | 119±39 | 90±35* | 64±24* | 22.45 | <0.001 | |
| AS&AR | 28 | 98±33 | 82±29 | 66±24* | 48±17* | 18.64 | <0.001 | |
LVEF(%) | AS | 20 | 50±8 | 53±7 | 56±6* | 63±3* | 14.24 | <0.001 |
| AR | 37 | 45±7 | 48±7 | 51±7* | 58±6* | 24.93 | <0.001 | |
| AS&AR | 28 | 46±8 | 49±8 | 53±7* | 60±5* | 20.01 | <0.001 | |
LVFS(%) | AS | 20 | 26±4 | 28±4 | 29±3* | 33±2* | 16.33 | <0.001 |
| AR | 37 | 23±4 | 25±4 | 26±4* | 31±4* | 23.80 | <0.001 | |
| AS&AR | 28 | 24±5 | 25±4 | 28±5* | 32±4* | 13.92 | <0.001 | |
IVST(cm) | AS | 20 | 1.43±0.21 | 1.42±0.19 | 1.35±0.18 | 1.19±0.13* | 7.91 | <0.001 |
| AR | 37 | 1.23±0.11 | 1.23±0.11 | 1.20±0.12 | 1.04±0.18* | 17.08 | <0.001 | |
| AS&AR | 28 | 1.33±0.15 | 1.33±0.16 | 1.26±0.13 | 1.13±0.09* | 13.92 | <0.001 | |
LVPWT(cm) | AS | 20 | 1.31±0.12 | 1.28±0.28 | 1.24±0.11 | 1.09±0.10* | 7.47 | <0.001 |
| AR | 37 | 1.18±0.11 | 1.18±0.10 | 1.15±0.11 | 0.98±0.09* | 30.65 | <0.001 | |
| AS&AR | 28 | 1.24±0.10 | 1.25±0.10 | 1.21±0.09 | 1.03±0.09* | 32.98 | <0.001 | |
AV Vmax(mmHg) | AS | 20 | 482.14±87.73 | 248.05±29.11* | 237.15±27.74* | 196.85±33.40* | 128.04 | <0.001 |
| AR | 37 | 190.73±18.58 | 188.35±18.08 | 185.49±18.10 | 183.46±16.39 | 1.62 | 0.204 | |
| AS&AR | 28 | 458.01±78.22 | 265.29±34.54* | 254.04±38.97* | 207.93±29.56* | 142.27 | <0.001 | |
AV PGmean(mmHg) | AS | 20 | 56.88±20.35 | 18.35±4.83* | 14.90±5.58* | 9.80±3.65* | 82.52 | <0.001 |
| AR | 37 | 10.86±2.54 | 9.68±2.29 | 9.08±2.14 | 8.73±1.81* | 9.00 | 0.001 | |
| AS&AR | 28 | 50.94±16.80 | 17.89±4.24* | 14.75±4.76* | 8.96±3.05* | 116.95 | <0.001 |
Tab.3
PVL parameters of patients in various groups"
| Group | n | Parameter | PVL | F/χ2 | P | ||
|---|---|---|---|---|---|---|---|
| 1 week after operation | 3 months after operation | 6 months after operation | |||||
| AS | 20 | Width(l/cm) | 0.06±0.12 | 0.04±0.09 | 0.02±0.05 | 1.100 | 0.340 |
| Case[n/(%)] | 4(20.0) | 4(20.0) | 2(10.0) | 1.035 | 0.749 | ||
| AR | 37 | Width(l/cm) | 0.05±0.12 | 0.03±0.08 | 0.01±0.32* | 1.905 | 0.044 |
| Case[n/(%)] | 5(13.5) | 4(10.8) | 1(2.7) | 3.211 | 0.305 | ||
| AS&AR | 28 | Width(l/cm) | 0.05±0.13 | 0.03±0.07 | 0.03±0.06 | 2.666 | 0.076 |
| Case[n/(%)] | 4(14.3) | 2(7.1) | 2(7.1) | 1.113 | 0.710 | ||
| 1 | 李 喆, 郭 帅, 叶蕴青, 等. 中国中重度主动脉瓣疾病患者的临床特点及预后: 来自China-VHD研究的分析[J]. 中国循环杂志, 2022, 37(4): 322-328. |
| 2 | 张 泽, 蒋 伟, 李思聪, 等. 全胸腔镜微创心脏手术临床疗效分析[J]. 中国临床新医学, 2023, 16(4): 375-378. |
| 3 | KHEIRI B, OSMAN M, BAKHIT A, et al. Meta-analysis of transcatheter aortic valve replacement in low-risk patients[J]. Am J Med, 2020, 133(2): e38-e41. |
| 4 | 罗一纯, 刘路路, 石 峻, 等. 应用J-Valve瓣膜经导管主动脉瓣置换术治疗高危单纯主动脉瓣反流多中心研究早期临床结果[J]. 中国胸心血管外科临床杂志, 2019, 26(8): 737-743. |
| 5 | 时应路, 张成鑫, 郭志祥, 等. 经心尖途径经导管主动脉瓣置换术治疗主动脉瓣关闭不全的早期疗效分析[J]. 中国胸心血管外科临床杂志, 2023, 30(8): 1116-1120. |
| 6 | 张 航, 安景辉, 刘 苏, 等. 经心尖经导管主动脉瓣置换术治疗主动脉瓣膜病变的临床研究[J]. 心脑血管病防治, 2023, 23(11): 47-48, 52. |
| 7 | SHI J, WEI L, CHEN Y, et al. Transcatheter aortic valve implantation with J-valve: 2-year outcomes from a multicenter study[J]. Ann Thorac Surg, 2021, 111(5): 1530-1536. |
| 8 | 孙艳丹, 李昱茜, 白 炜, 等. 三维经食管超声心动图在心尖入路经导管主动脉瓣置换术中的应用价值[J]. 临床超声医学杂志, 2023, 25(1): 58-61. |
| 9 | BENFARI G, SETTI M, NISTRI S, et al. Relevance of functional mitral regurgitation in aortic valve stenosis[J]. Am J Cardiol, 2020, 136: 115-121. |
| 10 | ILIUTA L, ANDRONESI A G, DIACONU C C, et al. Diastolic versus systolic left ventricular dysfunction as independent predictors for unfavorable postoperative evolution in patients with aortic regurgitation undergoing aortic valve replacement[J]. Medicina (Kaunas), 2022, 58(11): 1676. |
| 11 | 宋 羿, 张大发. 主动脉瓣置换治疗主动脉瓣膜疾病的临床效果[J]. 右江民族医学院学报, 2020, 42(1): 61-63. |
| 12 | PANÇ C, YILMAZ E, GÜRBAK İ, et al. Effect of prognostic nutritional index on short-term survival after transcatheter aortic valve implantation[J]. Turk Kardiyol Dern Ars, 2020, 48(6): 585-593. |
| 13 | 金朝龙, 史学功, 林先和, 等. 实时三维经食道超声心动图在室间隔缺损微创封堵术中的应用[J]. 安徽医科大学学报, 2018, 53(5): 812-815. |
| 14 | BLEAKLEY C, MONAGHAN M. 3D transesophageal echocardiography in TAVR[J]. Echocardiography, 2020, 37(10): 1654-1664. |
| 15 | MEHTA A, SALE S, CAPDEVILLE M. The deployment of valve academic research consortium 3 (VARC-3): new endpoints, broader definitions, and plenty of unanswered questions[J]. J Cardiothorac Vasc Anesth, 2021, 35(12): 3463-3466. |
| 16 | 冯晔子, 张申伟, 马倩倩, 等. 主动脉瓣重度狭窄经导管主动脉瓣置换术后患者围术期效果观察[J]. 心肺血管病杂志, 2019, 38(11): 1146-1149. |
| 17 | 周广为, 李 宁, 费 翔, 等. 二维超声心动图评价经导管主动脉瓣置入术后早期左心形态及收缩功能[J]. 第二军医大学学报, 2020, 41(8): 864-870. |
| 18 | LIU L, PENG Y, SHI J,et al. Initial experience with repositionable J-Valve for severe aortic regurgitation: a single-center experience[J].J Cardiovasc Surg(Torino),2022,63(4):521-528. |
| 19 | SAMMOUR Y, KRISHNASWAMY A, KUMAR A, et al. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2021, 14(2): 115-134. |
| 20 | AUFFRET V, PURI, URENA M, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives[J]. Circulation, 2017, 136(11): 1049-1069. |
| 21 | SCHOECHLIN S, HEIN M, BRENNEMANN T, et al. 5-year outcomesafter transcatheter aortic valve implantation: focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters[J]. Cathet Cardio Intervent, 2022, 99(5): 1582-1589. |
| 22 | LAAKSO T, LAINE M, MORIYAMA N, et al. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement[J]. Eur J Cardiothorac Surg, 2020,58(6):1145-1152. |
| 23 | XUE Y, ZHOU Q, LI S, et al. Transapical transcatheter valve replacement using J-valve for aortic valve diseases[J]. Ann Thorac Surg, 2021, 112(4):1243-1249. |
| 24 | 中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经导管主动脉瓣置换术中国专家共识(2020更新版)[J]. 中国介入心脏病学杂志, 2020, 28(6): 301-309. |
| 25 | SCHEWEL D, FRERKER C, SCHEWEL J, et al. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation[J]. Catheter Cardiovasc Interv, 2015, 85(3): 502-514. |
|